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Abstract
Background:  Glaucoma is a common disease but its molecular etiology is poorly understood. It
involves retinal ganglion cell death and optic nerve damage that is often associated with elevated
intraocular pressure. Identifying genes that modify glaucoma associated phenotypes is likely to
provide insights to mechanisms of glaucoma. We previously reported glaucoma in DBA/2J mice
caused by recessive alleles at two loci, isa and ipd, that cause iris stromal atrophy and iris pigment
dispersion, respectively. A approach for identifying modifier genes is to study the effects of specific
mutations in different mouse strains. When the phenotypic effect of a mutation is modified upon
its introduction into a new strain, crosses between the parental strains can be used to identify
modifier genes. The purpose of this study was to determine if the effects of the DBA/2J derived isa
and ipd loci are modified in strain AKXD-28/Ty.
Results:  AKXD-28/Ty mice develop glaucoma characterized by intraocular pressure elevation,
retinal ganglion loss, and optic nerve excavation. In AKXD-28/Ty,  isa causes an iris stromal atrophy
phenotype as in DBA/2J. However, the iris pigment dispersion phenotype associated with ipd in
DBA/2J does not occur in AKXD-28/Ty. Additionally, a greater severity and speed of retinal and
optic nerve damage following intraocular pressure elevation in AKXD-28/Ty compared to DBA/2J
mice suggests that AKXD-28/Ty is more susceptible to pressure-induced cell death.
Conclusions:  The consequences of the ipd and isa mutations are modified in the AKXD-28/Ty
background. These strains provide a resource for the identification of modifier genes that modulate
pigment dispersion and susceptibility to pressure-induced cell death.
Background
Glaucoma is a prevalent group of retinal and optic nerve
neuropathies that currently renders approximately 67
million people worldwide at risk for developing signifi-
cant vision loss, including blindness [1]. Glaucoma in-
volves the death of retinal ganglion cells (RGCs) and
their axons, and is characterized by atrophic excavation
of the optic nerve [2,3,4]. Glaucoma is usually associated
with high intraocular pressure (IOP) resulting from an
increased resistance to drainage of aqueous humor. Not
all people with high IOP develop glaucoma [5], however,
suggesting that other factors, such as genetic susceptibil-
ity to pressure-induced damage, interact with IOP to
cause damage. The occurrence of glaucomatous damage
in individuals without high IOP and the benefit of lower-
ing IOP in some of these individuals further suggest mul-
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tiple factors determine an individual's susceptibility to
pressure-induced damage [6]. The nature of the factors
participating in glaucomatous events, particularly those
influencing disease progression and modifying disease
severity in different individuals, remain largely un-
known. Increased understanding of factors contributing
to glaucoma will suggest new therapeutic strategies and
will likely lead to improved clinical management.
Glaucomatous phenotypes have been observed in a
number of mammalian species, including mice [7,8,9].
Mice can be clinically and histologically analyzed
throughout the course of a disease and their genes can be
altered to study the molecular framework underlying pa-
thology [10]. As a consequence, mouse models are useful
for identifying and characterizing the effects of causative
genes necessary for glaucoma development, and for
characterizing the genes and molecular pathways that
participate in or modify disease progression [9]. A collec-
tion of glaucomatous mouse strains with phenotypic dif-
ferences would facilitate research to understand the
complexity of glaucoma. As part of our efforts to under-
stand glaucoma, we are screening for and characterizing
glaucoma in aged mice of various strains. We are partic-
ularly interested in documenting differences in glauco-
ma phenotypes between strains of mice that share the
same causative genes. This information will provide an
experimental basis for identifying genes and mecha-
nisms that modify the progression or severity of glauco-
ma. Here we report differences in genetic susceptibility
to glaucoma-associated phenotypes between two related
inbred strains of mice, AKXD-28/Ty (AKXD28) and
DBA/2J (D2).
D2 mice develop glaucoma involving a harmful increase
of IOP followed by RGC loss and optic nerve damage [11].
The increase in IOP is associated with an iris disease in-
volving iris pigment dispersion (IPD), iris stromal atro-
phy (ISA), and the formation of synechiae that block
aqueous humor drainage. The iris pigment dispersion
and iris stromal atrophy phenotypes are caused by dis-
tinct recessive alleles at the ipd and isa loci, respectively
[12]. The IPD phenotype in D2 mice is similar to human
pigment dispersion syndrome, a condition that often
leads to pigmentary glaucoma [12, 13], and involves de-
generation of the iris pigment epithelium [12, 14]. Caus-
ative genes for pigment dispersion remain to be
identified [12, 15]. The gene responsible for the ISA phe-
notype is tightly linked to the tyrosinase related protein
1 gene (Tyrp1) [12], which also regulates coat color. D2
mice have a mutant allele of this gene (Tyrp1b) and a
brown coat color [16]. In previously studied genetic
backgrounds, homozygosity for D2 alleles of both isa and
ipd results in iris atrophy that severely affects both the
iris stroma and iris pigment epithelium, leading to a se-
verely atrophic and largely transparent iris in old mice
[11, 12].
AKXD28 is a recombinant inbred strain derived by in-
breeding offspring from an intercross between mice of
the D2 and AKR/J strains [17]. AKXD28 mice, therefore,
have a genetic background that is a mix of the D2 (glau-
comatous) and AKR/J (normal eyes with no obvious dis-
ease) genomes. Due to extensive inbreeding, all AKXD28
mice are genetically identical except for the sex chromo-
some difference between males and females. This genetic
uniformity is important for the analysis of complex dis-
eases because it allows repeated and therefore accurate
assessment of phenotypes associated with the AKXD28
mix of D2 and AKR/J genomes. AKXD28 mice inherited
the glaucoma causing ipd and isa alleles from strain D2.
This is evident by their brown coat color and the inherit-
ance of D2 derived microsatellite markers flanking these
loci [18,19,20,21,22,23]. To further assess the phenotyp-
ic consequences of ipd and isa and whether their effect is
modified in the AKXD28 genetic background, we per-
formed a detailed characterization of the ocular pheno-
type in AKXD28 mice.
As demonstrated here, AKXD28 mice develop an age re-
lated glaucoma involving increased IOP and optic nerve
damage, and they are a useful tool for glaucoma re-
search. The AKXD28 disease has a number of similari-
ties to that observed in D2 mice. Importantly, however,
two major differences exist between the disease in
AKXD28 and D2 mice housed in the same environment.
First, AKXD28 mice do not develop the IPD phenotype.
The absence of the IPD phenotype is surprising consider-
ing AKXD28's inheritance of the D2 chromosomal re-
gion containing the ipd gene, and likely results from
genetic differences between these strains. Understand-
ing these differences will be important for understanding
pigment dispersion, a common cause of human glauco-
ma. Second, although D2 and AKXD28 strains demon-
strate similar magnitudes of IOP, AKXD28 mice develop
more severe and more extensive retinal damage and are
more prone to optic nerve head excavation than D2 mice.
This suggests that compared to D2 mice, AKXD28 mice
have an increased genetic susceptibility to pressure-in-
duced damage. Identifying the genes that differ between
AKXD28 and D2 mice and that modify the progression
and severity of pressure-induced retinal cell death will be
important for understanding mechanisms killing cells in
glaucoma and may ultimately lead to improved patient
care.BMC Genetics (2001) 2:1 http://www.biomedcentral.com/1471-2156/2/1
Results
AKXD28 is a recombinant inbred mouse strain that in-
herited the glaucoma associated isa and ipd alleles from
strain D2. To investigate the effects of these alleles in
AKXD28 mice, and the potential presence of modifier lo-
ci, we examined the eyes of AKXD28 mice at ages from 2
to 28 months, as summarized in Table 1. Although the
presence and severity of specific disease features were
variable between mice of the same age, the disease sever-
ity clearly increased progressively with age. To ensure ac-
curate phenotypic comparisons between the AKXD28
and D2 strains both strains were housed at the same time
in the same environment and fed the same diet. The phe-
notype of D2 mice was previously reported and is not
presented in detail here [11,12]
AKXD28 develop ISA but not IPD
Consistent with the inheritance of isa from strain D2, the
iris stroma of AKXD28 mice atrophied with age (Figure
1). The first signs of ISA were small focal peripheral tran-
sillumination defects at 6 to 8 months of age. Iris stromal
atrophy was histologically evident in most eyes by 15
months. ISA became progressively more severe, pro-
foundly affecting all eyes by 23 months (Table 1, Figure
1).
AKXD28 mice contain D2 derived alleles for markers
Mtv23 and D6Nds3 which are located approximately 9.5
cM proximal and 5 cM distal to ipd, respectively [12, 22,
23]. Additionally, AKXD-28/Ty mice contain D2 derived
microsatellite markers for D6Mit207,  D6Mit33, and
D6Mit93 which subdivide this region and are tightly
linked to ipd (data not shown). Despite inheritance of the
ipd chromosomal segment from strain D2, both histolog-
Table 1: Clinical and histological findings in AKXD-28/Ty eyes.
Clin Histo
Age
(months) ISA TRAN DP ISA PAS PS RGCD ONA ONC INL
6-8 0/1212 /12 0/12 0/8 0/8 0/8 0/8 0/8 0/1 0/8
12 per
9-14 52/78 78/78 0/78 2/8 7/8 6/8 2/8 0/4 0/3 0/8
36 mi 70 mi 2 mi 7 mi 4 mi 2 mi b
16 mod 8 mo 2 mo
15-22 60/60 a 60/60 a 0/60 a 11/12 12/12 9/12 11/12 8/10 7/7 7/12
24 mi 20 mi 2 mi 4 mi 3 mi 1 mi c 1 mi c 1 mo c
36 mo 40 mo 7 mo 4 mo 1 mo 10 sev d 3 mo d 6 sev d
2 sev 4 sev 5 sev 4 sev d
23-28 26/26 26/26 1/26 25/25 23/23 24/25 25/25 23/23 21/21 24/25
26 sev 26 sev 25 sev 1 mi 2 mi 25 sev 1 mo 21 sev
15 mo 9 mo 22 sev
7 sev 13 sev
Clin = clinical, Histo = histological. a All were 15 months old; b All were 14 months old; c All were 17 months old; d All were 18 to 22 months old. 
Summary of Clinical and histological phenotypes in AKXD28 eyes. Clinical and histologic examinations were performed with different co-
horts of mice. The age groups are arranged so that the overall prevalence and severity of specific disease features within each group are similar. In 
general, age groups are not skewed with mice of a particular age, except that the 15-22 month old group examined clinically consists of 15 month 
old mice. Mice less than 6 months old were characterized by normal clinical exams and histology but are not included in Table 1. The numerator 
indicates the number of eyes exhibiting the lesion, whereas the denominator indicates the number of eyes successfully analyzed for that lesion. The 
number of eyes with a finding of a specific severity is shown in italics. Phenotypes were ranked as peripheral (per), mild (mi), moderate (mo), or 
severe (sev) (see Materials and methods, and ref 11). Clinical abbreviations: iris stromal atrophy (ISA), iris transillumination (TRAN), and dispersed 
pigment (DP). Histologic abbreviations: iris stromal atrophy (ISA), peripheral anterior synechiae (PAS), posterior synechiae (PS), retinal ganglion cell 
depletion (RGCD), optic nerve atrophy (ONA), optic nerve cupping (ONC), and inner nuclear layer cell loss (INL). Other phenotypes not listed 
here include corneal neovascularization and corneal calcification that occurred in some mice, and cataracts whose incidence increased with age and 
that were present in all 23 month old or older mice. Despite gentle handling and great care, clinical examination induced subconjunctival hemorrhage 
in approximately 30-50% of AKXD28 mice. Though less frequent, spontaneous and handling induced vascular hemorrhage into the anterior chamber 
(hyphema) also was observed in a number of AKXD28 mice. These bleeding phenotypes occur only rarely in other strains we have studied. BMC Genetics (2001) 2:1 http://www.biomedcentral.com/1471-2156/2/1
ical and clinical analysis of AKXD28 irides and anterior
chambers failed to detect the presence of IPD at all ages
examined. IPD is characterized by deterioration of the
iris pigment epithelium with accumulation of dispersed
Figure 1
AKXD28 develop ISA but not IPD. Representative iris phenotypes in aging AKXD28 (a-c and g, h) and D2 (d-f and i)
mice are shown. Age and disease severity increase from left to right. (a, d) Two month old AKXD28 and D2 mice have a nor-
mal, complex iris morphology with clearly evident iris details including crypts, small central pupil, prominent peripupillary
sphincter muscle, and pupillary ruff. (b, e) At 12 months AKXD28 (b) have iris stromal atrophy characterized by loss of iris
detail, thinning of the iris stroma with exposure of the sphincter muscle (arrowhead in b), and mild transillumination defects
(arrow). Dispersed pigment is not prominent in the anterior chamber. The eyes of similarly aged D2 mice (e) are more
severely affected with both stromal atrophy and iris pigment dispersion. The stromal atrophy is characterized by abnormally
shaped pupils, exposure of the sphincter, and loss of iris detail while the pigment dispersion is evidenced by the prominent
accumulation of pigment on the front of the iris and lens (arrowheads in e). (c, f) 26 month old AKXD28 and D2 mice have
marked stromal atrophy with enlarged irregular pupils, iris holes, and increased transillumination. In D2, severe loss of both iris
stromal and iris pigment epithelium pigmentation due to the ISA and IPD phenotypes results in large transparent iris regions. In
contrast, the AKXD28 iris remains generally pigmented due to the lack of IPD and retention of much of the pigment epithe-
lium. Histologic analysis confirms the presence of ISA and lack of IPD in AKXD28 mice. (g) In a young AKXD28 mouse the iris
has a robust stroma (S) and pigment epithelium (P) that are separated by the dilator muscle (masked by pigment in this section
but located at the level of the arrows). (h) Although severity varies locally, the stroma of old AKXD28 mice is severely atro-
phied and almost non-existent in many places (arrow). The iris pigment epithelium (arrowhead) of old mice has a flattened
morphology but remains remarkably intact considering the overall condition of the iris. (i) In old D2 mice, both the iris stroma
and iris pigment epithelium are severely atrophic.BMC Genetics (2001) 2:1 http://www.biomedcentral.com/1471-2156/2/1
pigment and pigment filled cells in the anterior chamber
and on the front of the iris and lens [12] (Figure 1e). No
pigment dispersion or accumulation was observed in
AKXD28 eyes (Figure 1a,1b,1c), and the iris pigment ep-
ithelium remained remarkably intact considering the se-
vere iris stromal atrophy (Figure 1h). The overall
condition of the iris in old AKXD28 versus old D2 mice
also indicated the lack of the IPD phenotype in AKXD28.
D2 mice succumb to both ISA and IPD, and develop iris
atrophy that progresses to the point of transparency over
most of the iris (Figure 1f). The irides of AKXD28 eyes
maintain substantially greater tissue integrity and pig-
mentation (compare Figure 1c to 1f and 1h to 1i).
Anterior synechiae and increased IOP in AKXD28
The ISA phenotype in D2 mice involves deterioration of
the iris stroma and release of cellular debris into the an-
terior chamber. This leads to the formation of adhesions
(anterior synechiae) that block aqueous humor access to
its drainage pathways including the trabecular mesh-
work and Schlemm's canal in the iridocorneal angle [11,
12]. AKXD28 mice similarly develop iris stromal atro-
phy, anterior synechiae, and IOP elevation (Figure 2). In
AKXD28, the synechiae were first evident at 9 months,
and were extensive in most eyes by 15 to 22 months of
age (Table 1).
To assess the functional relationship between these mor-
phological abnormalities and aqueous drainage, we de-
termined the IOPs of AKXD28 mice at various ages
(Figure 2). IOP increased significantly with age
(P=0.0001) and pressure elevation followed a time
course consistent with obstruction of aqueous humor
drainage by extensive anterior synechiae formation. Al-
though there were no obvious histologic differences be-
tween males and females, gender had a significant effect
on the timing of IOP elevation (P=0.008). Among fe-
males, the mean IOP increased from 12.9 ±  0.3 mmHg at
7 to 10 months (when synechiae were absent or mild) to
a peak value of 19.8 ±  1.8 mmHg at 15-18 months (when
synechiae were often moderate or severe). The IOP of
males showed an increase from 14.9 ±  0.4 mmHg at 7 to
10 months to a peak of 18.9 ±  1.0 mmHg at 19-21 months.
The magnitudes of IOP elevation were similar to those in
D2 mice [11].
Vitreous glutamate levels increase when IOP is elevated
in various species and this increase is associated with
RGC death [24,25,26]. As an initial effort to assess gluta-
mate levels in AKXD28 mice, vitreous was collected from
mice of different ages and subjected to amino acid anal-
ysis. In this study, we analyzed two pools of samples from
14 month old mice and two pools of samples from 16
month old mice. Pooling was necessary due to the small
volume of vitreous collected, and each pool consisted of
2 to 4 eyes (see Materials and methods). In this study,
vitreous glutamate levels were 13.2 ±  1.7 µ M in 14 month
old mice (when IOP is generally normal) and 29.2 ±  4.7
µ M in 16 month old mice (when IOP is often elevated).
AKXD28 develop glaucomatous neuropathy
AKXD28 mice develop several glaucomatous abnormal-
ities. All retinas had a normal appearance until 14
months when mild loss of retinal ganglion cells was ob-
served in some mice (Table 1). All mice over 18 months
of age had severe ganglion cell loss both peripherally and
close to the optic nerve (Figure 3, Table 1). Atrophic ex-
cavation of the optic nerve head was evident histological-
ly and by clinical fundus examination in old but not in
young mice (Figure 3, Table 1). Fundus examination was
not possible in many old mice due to corneal opacities
and cataracts.
To further examine the progression of optic nerve dam-
age, optic nerve cross sections from male and female
mice of differing ages were analyzed (Figure 4). Optic
nerve damage was detected closely following the period
of increased IOP. Moderate or severe optic nerve damage
was first observed in some 17 month old mice (3 of 12)
and occurred in almost all 19-20 month old mice (20 of
22). Interestingly, optic nerve damage occurred earlier in
females than in males. Damage was detectable in female
but not male nerves at 17 months. By 19-20 months all fe-
male nerves were severely affected, whereas, approxi-
mately half of the male nerves were mildly or moderately
affected (P=0.02, Chi-square) (Figure 4d).
Retinal and optic nerve damage is more severe in AKXD28 
than D2
Retinal damage in AKXD28 eyes was more severe than in
D2 eyes (Figure 3, Table 1, and Ref. [11]). In AKXD28
mice, IOP elevation was first noted in a few mice at 11
months and mild RGC depletion (defined here as loss of
cells in the RGC layer) was initially observed at 14
months. By 18 months RGC loss was severe in all
AKXD28 eyes. By contrast, D2 mice exhibit a slower and
milder retinal disease following increased IOP (compare
Figure 3c to 3f). In D2 mice, IOP elevation was first ob-
served in some mice at 6 months. Mice at 18 or 19
months had no more than a moderate loss of RGCs, and
only 1 of 11 mice older than 20 months had severe RGC
loss. Paralleling RGC loss, optic nerve head excavation or
cupping was also more severe and more frequent (P <
0.0001, Chi-square) in AKXD28 than D2 mice. Optic
nerve excavation was histologically evident in 27 of 27
AKXD28 mice that were 18 months or older and was typ-
ically severe (Table 1). The severe atrophy extended to a
level outside of the inner nuclear layer (INL) and often
outside the choroid (Figure 3e). Optic nerve excavation
occurred in only 11 of 24 D2 mice that were 18 months orBMC Genetics (2001) 2:1 http://www.biomedcentral.com/1471-2156/2/1
older. The excavation in these mice never extended deep-
er than the INL and was never rated severe. Clinical fun-
dus examinations agreed with histological findings
showing obvious, severe optic nerve damage in success-
fully analyzed old AKXD28 eyes but not in D2 eyes.
In addition to the typical glaucomatous changes men-
tioned above, an obvious loss of cells in the INL occurred
in almost all AKXD28 mice 23 months old and older (Ta-
ble 1, Figure 3c). In some AKXD28 mice older than 26
months, the disease progressed to affect the entire retina
with substantial loss of both INL cells and photorecep-
tors. This is in contrast to the phenotype in D2 mice, in
which INL cell loss sometimes occurred but extensive
damage throughout the retina was never observed (Fig.
3f).
Discussion
Identifying genes that modify glaucoma associated phe-
notypes is likely to provide insights to mechanisms of
glaucoma. An approach for identifying modifier genes is
to transfer mutations that produce characterized pheno-
types into different mouse strains [27,28,29,30,31,32].
When the phenotypic effect of a mutation is modified
upon its introduction into a new strain, crosses between
the parental strains can be used to identify modifier
genes. Also, the phenotypic characteristics of the new
mutant strain may make it a valuable new model of the
human disease. In this study, we determined the effects
of the D2 derived ipd and isa alleles in the AKXD28 ge-
netic background. We show that AKXD28 mice develop
elevated IOP and glaucoma with similarities to the dis-
ease observed in D2 mice [11, 12]. However, there are
also significant phenotypic differences between the dis-
ease in D2 and AKXD28 mice. This suggests that the ge-
Figure 2
Anterior synechiae and elevated IOP in AKXD28. (a) Young mice have normal, unobstructed iridocorneal angles. The
angle has a well developed trabecular meshwork (TM, arrowhead) and open Schlemm's Canal (SC). (b) A large anterior syn-
echia (arrow) has occluded the TM and SC in a 14 month old mouse. As shown in c (and see Table 1), the formation of syn-
echiae is followed by IOP elevation. Two standard deviations (2 SD) above the mean IOP for 7-10 month mice is indicated by
the dashed line (females) and a full line (males). Ciliary body atrophy occurs in some mice and its incidence increases with age.
Although histologic analysis and IOP measurement were not performed on the same eyes, it seems likely that ciliary body atro-
phy explains the drop in female IOP at 19 to 21 months. Original magnifications 400X.BMC Genetics (2001) 2:1 http://www.biomedcentral.com/1471-2156/2/1
netic constitution of these strains result in differing
genetic susceptibilities to glaucoma associated pheno-
types and may allow the identification of modifier genes.
An AKR/J modifier(s) likely suppresses IPD in AKXD28
A significant difference between D2 and AKXD28 mice is
the lack of an overt IPD phenotype in AKXD28, despite
inheritance of the ipd allele from D2. In AKXD28, there
is no obvious pigment dispersion, the iris pigment epi-
thelium remains remarkably intact, and the irides of old
mice remain pigmented. Evidence that the ipd contain-
ing chromosomal region in AKXD28 is derived from D2
includes inheritance of D2 alleles of microsatellite mark-
ers spanning an approximately 14.5 cM chromosomal re-
gion surrounding the ipd locus (delimited by the markers
Mtv23 and D6Nds3) [22, 23]. Though unlikely, the pos-
Figure 3
Severe retinal and optic nerve damage in AKXD28 mice. The panels are arranged to display the progressive increase
in severity from left to right. All images are from strain AKXD28 mice except for  f, (D2) and g,h (AKXD28B6F1 X AKXD28,
backcross N2). (a) Young AKXD28 retinas have normal morphology. The retinal ganglion cell layer (G) is continuous and 1-2
cells thick. The inner nuclear layer is approximately 5 to 6 cells thick (flanked by arrowheads). (b) Moderately affected
AKXD28 retinas contain fewer retinal ganglion cells while the inner nuclear layer has some cell loss but remains relatively nor-
mal. (c) Severely affected AKXD28 retinas have very few retinal ganglion cells, the inner nuclear layer (arrow) is only 1-2 cells
thick, and the total thickness of the retina is greatly reduced. Focal loss of photoreceptors is also present. The image repre-
sents the severe phenotype attained by all old AKXD28 eyes; some old eyes have even more cell loss with severe photorecep-
tor depletion and the remnants of retina are very thin. This severe atrophy does not occur in D2 mice (see  f for a typical
severe D2 retina). (d) Normal optic nerve head of a young mouse characterized by a thick nerve fiber layer entering the optic
nerve (arrows), a central vessel (V), and well organized pial septae (P). (e) Advanced optic nerve excavation (arrowheads) with
atrophy extending to a level external to the choroid (C). There is severe peripapillary atrophy with thinning of most retinal lay-
ers near the nerve. Although not prominent in this image, gliosis was frequently observed in severely damaged nerves. (f) Rep-
resentative retina from a D2 mouse exhibiting advanced end stage retinal disease typical for that strain. Note that the inner
nuclear layer is relatively unaffected and overall retinal thickness is maintained. (g) Normal fundus. (h) Glaucomatous fundus
with an asymmetric and severely excavated optic nerve head (arrowhead). Peripapillary chorioretinal atrophy is also distinctly
recognizable in this eye. These fundi are from backcross mice since all old AKXD28 mice had severe cataracts that made pho-
tography very difficult. The appearance of these backcross fundi closely resembles those of age matched AKXD28. Original
magnifications 400X (a,b,c,f,) and 200X (d,e).BMC Genetics (2001) 2:1 http://www.biomedcentral.com/1471-2156/2/1
sibility of an undetected recombinational rearrangement
within this region that placed an AKR/J allele of the gene
that causes IPD on the AKXD28 chromosome cannot be
ruled out. The presence in AKXD28 of the D2 allele of
D6Mit33, which maps to the same position as ipd (25.5
cM), argues against such a rearrangement [12, 21]. Other
explanations for the absence of an IPD phenotype in
AKXD28 include: inheritance of an AKR/J modifier
gene(s) that suppresses the IPD phenotype, a spontane-
ous reversion of the ipd mutation in AKXD28 mice, or
the spontaneous occurrence and fixation of the ipd mu-
tation in strain D2 after the derivation of the AKXD28
strain. Inheritance of an AKR/J modifier seems the most
likely explanation but elucidation of the molecular na-
ture of the ipd mutation or the mapping of a modifier
gene(s) is necessary to distinguish among the possibili-
ties.
IOP elevation occurs earlier in females
Female AKXD28 mice exhibit increased IOP earlier than
males. Nerve damage was also first observed in females.
Our clinical and histological studies identified no obvi-
ous gender differences in anterior segment pathology
that account for this. It must be remembered, however,
that our histological analysis accounts for a small portion
of the eye and so differences in the prevalence or severity
of anterior synechiae may have been missed. Further ex-
periments including more detailed analysis of the aque-
ous drainage system are necessary to understand why
IOP elevation occurs earlier in females than males. Inter-
estingly, D2 females also exhibit increased IOP prior to
males [11]. Sex-specific differences in human glaucoma
susceptibility have been reported in some, but not all hu-
man studies [33,34,35,36,37]. In general, sex-specific
differences in human glaucoma may be difficult to iden-
tify or interpret because of genetic differences and un-
controlled environmental factors between patients that
may alter the phenotype. Since they are inbred and envi-
ronment can be highly controlled, AKXD28 mice provide
an experimental resource for examining the biological
significance of gender for susceptibility to events that el-
evate IOP.
AKXD28 and D2 have different susceptibilities to pressure-
induced damage
Overall, the progression of optic nerve and retinal dis-
ease in AKXD28 mice supports a pressure-induced etiol-
ogy. Optic nerve and retinal damage were only observed
at ages after high IOP was detected. Following the period
of increased IOP, the retinas and optic nerves of aged
AKXD28 mice undergo substantially greater damage
than those of D2 mice. The damage also occurs more rap-
idly after IOP elevation is first detected in AKXD28 com-
pared to D2. Strikingly, all old AKXD28 mice have severe
retinal ganglion cell loss typically associated with severe
optic nerve excavation, whereas, few old D2 mice have
severe RGC loss and optic nerve excavation is rarely, if
ever severe (defined here as extending to a level out side
of the inner nuclear layer). Additionally, following initial
RGC loss, most AKXD28 eyes exhibit thinning of the in-
ner nuclear layer, and some mice older than 26 months
show severe depletion of all retinal layers. Such severe
and extensive retinal damage never occurs in strain D2.
The RGC layer is primarily affected in most old D2 mice
with the occurrence of mild inner nuclear layer cell loss
and possibly, very mild photoreceptor loss in only some
mice. In our studies, the occurrence of outer retinal dam-
age was only observed in old AKXD28 eyes with late
stage disease, typically several months after signs of
glaucoma were evident, and was a late consequence of
disease progression. Although RGCs are generally ac-
cepted to be the major cell type affected in human glau-
coma, and to our knowledge INL and photoreceptor cell
loss similar to that in AKXD28 has not been reported,
there is evidence for INL and photoreceptor cell involve-
ment in some human and monkey cases
[38,39,40,41,42,43].
Both AKXD28 and D2 have similar magnitudes and du-
rations of increased IOP, with the duration appearing to
last a little longer in the more mildly affected D2 strain.
The IOP distribution of D2 females is significantly ele-
vated from 8 to 12 months of age and AKXD28 females
from 15 to 18 months. Although the duration of IOP ele-
vation in AKXD28 males is not yet characterized, female
AKXD28 mice are affected more severely than D2 mice
of either sex. Thus, the duration and magnitude of IOP
elevation does not seem to underlie the more severe
Figure 4
Optic nerve damage in AKXD28 mice. Representative
nerve  sections  scored  as  (a)  mild,  (b)  moderate,  and  (c)
severe  are  shown.  (d)  Nerve  damage  is  first  evident  in
females. At 19 to 20 months all females are severely affected
whereas approximately half of the males are. Original magni-
fications 630X.BMC Genetics (2001) 2:1 http://www.biomedcentral.com/1471-2156/2/1
damage in AKXD28. The greater severity and speed of
damage following IOP elevation in AKXD28 compared
to D2 mice housed in the same environment, therefore,
suggests that AKXD28 is more susceptible to pressure-
induced cell death. Future experiments involving D2 and
AKXD28 may allow identification of genes(s) that mod-
ulate susceptibility to pressure-induced damage and that
may be relevant for human glaucoma. Identification of
genes that modify pressure-induced cell death and char-
acterization of the mechanisms by which they act will
broaden the knowledge base from which informed deci-
sions regarding patient counseling, screening, and treat-
ment are made.
Systems that may alter susceptibility to pressure-induced 
damage
Known characteristics of the AKR/J and D2 strains offer
few clues to AKXD28's increased susceptibility to pres-
sure-induced damage and all explanatory attempts are
speculative. The propensity for handling-induced hyphe-
ma and subconjunctival hemorrhage that we observe
(see Table 1) in AKXD28 may indicate vascular abnor-
malities with relatively weak blood vessels and capillary
beds. Weakened capillaries may not function optimally
in the face of elevated IOP resulting in some degree of
retinal ischemia that exacerbates retinal cell death. Reti-
nal ischemia is known to affect cell viability in the INL
and photoreceptor layers [44]. Ischemia would likely in-
voke glutamate induced neurotoxicity [45, 46].
Equally plausible is the possibility of differing neurotoxic
responses to glutamate or differences in the ability of
AKXD28 and D2 mice to buffer glutamate levels in the
face of high IOP. Acting through N-methyl-D-aspartate
receptors, glutamate is believed to be a potent initiator of
RGC neurotoxicity [26] and, as described here, the vitre-
ous of at least some AKXD28 mice contains elevated
glutamate concentrations when IOP is elevated. Studies
with human eyes have previously reported an increase in
vitreous glutamate levels from approximately 10 µ M in
non-glaucomatous eyes to 23 µ M in glaucomatous eyes
[24]. Also, chronic elevation of rat vitreous glutamate
levels from approximately 5-12 µ M to 26-34 µ M has pre-
viously been shown to be toxic to RGCs [25, 26]. The
higher vitreous glutamate concentrations we observed in
16 month old (29.2 ±  4.7 µ M) compared to 14 month old
(13.2 ±  1.7 µ M) AKXD28 mice would, therefore, be ex-
pected to damage the retina. Although these findings are
promising and implicate glutamate in retinal neurotoxic-
ity in AKXD28 mice, further experiments are needed to
completely characterize vitreous glutamate levels and
their relationship to IOP and glaucoma in this strain.
Molecules involved in glutamate metabolism, signaling,
or buffering are interesting candidates to alter suscepti-
bility to retinal cell death. An intriguing possibility is that
AKXD28 and D2 mice have differing responses to plate-
let-activating factor (PAF). PAF is a biologically active
phospholipid mediator. PAF acts by binding to a unique
G protein coupled transmembrane receptor, PTAFR,
that is broadly expressed in the eye [47]. Relevant activ-
ities of PAF include promoting ocular hypertension and
enhancing neural glutamate release [48,49,50]. Interest-
ingly, AKR/J airways have a strain specific hyper-re-
sponsive reaction to intravenously injected PAF [51]. A
hyper-responsiveness of AKXD28 ocular tissues to PAF
or increased activity of the PTAFR receptor mediated
signaling pathway could, therefore, contribute to the
pronounced retinal damage through potentiating gluta-
mate neurotoxicity.
Conclusions
We have documented the development of a disease in-
volving iris stromal atrophy and glaucoma in aged
AKXD28 mice. These results add to our understanding
of the natural history of glaucoma in mice and provide a
new animal model for studying glaucoma involving in-
creased IOP. Furthermore, careful phenotypic compari-
sons between the AKXD28 and D2 strains suggests that
the AKXD28 genome contains genetic modifiers that
suppress pigment dispersion and increase susceptibility
to pressure-induced retinal damage. These results pro-
vide a basis for future research to identify glaucoma
modifier genes and to dissect the molecular mechanisms
by which they act.
Materials and methods
Animal husbandry
All experiments were performed in compliance with the
Association for Research in Vision and Ophthalmology
Statement for Use of Animals in Ophthalmic and Vision
Research. Mice were housed in cages containing white
pine bedding and covered with polyester filters. The en-
vironment was kept at 21° C with a 14-h light:10-h dark
cycle. Mice were fed NIH31 (6% fat) chow ad libitum,
and their water was acidified to pH 2.8-3.2. All mouse
strains used for this study were routinely screened for se-
lect pathogens by The Jackson Laboratory's routine sur-
veillance program (see http://www.jax.org for specific
pathogens). The mouse strains used in this study were
DBA/2J (D2), AKXD-28/Ty (AKXD28), and C57BL/6J
(B6). Cohorts of D2 and AKXD28 mice were housed in
the same room and examined using identical protocols.
The majority of AKXD28 mice were aged and analyzed at
the same time as groups of D2 mice reported in a previ-
ous study [11]. Some AKXD28 mice were subsequently
analyzed and so additional D2 mice were aged and ana-
lyzed at the same time. The disease characteristics of the
additional D2 mice was the same as previously described
[11].BMC Genetics (2001) 2:1 http://www.biomedcentral.com/1471-2156/2/1
Clinical examinations
The anterior chambers of male and female AKXD28 mice
2-27 months of age were examined with a slit-lamp bi-
omicroscope (Haag-Streit, Mason, OH). Observed clini-
cal phenotypes were recorded at the time of examination
and rated as normal, mild, moderate, or severe based on
the following criteria. Iris stromal atrophy (ISA) involves
a loss of complex iris structure due to loss of iris stroma.
It was ranked as mild (minor loss of iris complexity),
moderate (notable lack of iris complexity and focal thin-
ning of iris), or severe (iris lacking complex morphology
and is thin, frequently with focal full thickness holes).
Transillumination (TRAN) refers to light passed through
the pupil and reflected off the back of the eye and
through depigmented regions of the iris. TRAN was
ranked as peripheral (transillumination limited to pe-
ripheral iris), mild (individual specks of transillumina-
tion across iris), moderate (individual specks and focal
areas of mass transillumination), or severe (majority of
iris transilluminates easily, frequently through holes).
Dispersed pigment (DP) refers to clinically visible accu-
mulations of pigment or pigment laden cells on anterior
segment surfaces, most frequently observed on the lens
or iris. Dispersed pigment is part of the iris pigment dis-
persion phenotype (IPD) that is caused by the D2 ipd al-
lele. Fundus examination was performed with pupils
dilated by a drop of 1% atropine sulfate and an indirect
ophthalmoscope (American Optical, Rochester, NY)
with a 60- or 90-diopter lens. Our method of fundus pho-
tography has been previously reported [52].
Ocular histologic processing
Enucleated eyes from AKXD28 mice 2-28 months old
were fixed for plastic sectioning (0.8% paraformalde-
hyde and 1.2% glutaraldehyde in either 0.1 M phosphate
buffer, pH 7.2, or 0.1 M cacodylate buffer, pH 7.2) or for
paraffin sectioning (3.2% formaldehyde, 0.7 M acetic ac-
id, 61% ethanol) as previously described [11, 12]. Serial
sagittal sections passing through the optic nerve were
collected, stained with hematoxylin and eosin, and ana-
lyzed for pathologic changes. To control for variation
with position, various phenotypes were only assessed at
specific ocular locations in high quality sections [11].
Thus, the number of eyes successfully analyzed differs
with the phenotype assessed. Optic nerve cupping was
only judged from sections containing central optic nerve.
Optic nerve atrophy, retinal ganglion cell death, and in-
ner nuclear layer cell loss were detectable in central sec-
tions and sections containing optic nerve that were
slightly off center. Ocular lesions were rated as normal,
mild, moderate, or severe using previously published cri-
teria [11]. Since cell counts were not performed, inner
nuclear layer cell loss was only rated as affected when ob-
vious cell loss was evident (typically at least 2 to 3 cell
layers missing). One D2 eye examined histologically was
excluded from the study because of the complicating
presence of a large corneal ulcer accompanied by severe
intraocular inflammation; this eye had a very severe ret-
inal phenotype and severe optic nerve damage.
Optic nerve histologic processing
Samples were processed as previously described [11]. Af-
ter initial fixation for 24-48 hours, optic nerves were
carefully dissected, postfixed with 1% osmium tetroxide,
and subsequently processed by standard procedures. A
few nerves were recovered from eyes previously embed-
ded in Historesin (Leica, Heidelberg, Germany). Cross
sections were cut at a thickness of 0.5-1.0 µ m, stained
with Toluidine Blue O, and analyzed for pathologic
changes. Using this technique, the axoplasm of degener-
ating axons appears dark [53]. The number of females
(F) and males (M) analyzed at each age (in months)
were: F13-14, n=3; M13-14, n=13; F17, n=7; M17, n=5;
F19-20, n=12; M19-20, n=10. The extent of nerve dam-
age was independently rated by 3 investigators (MGA,
RSS, SWMJ) who were unaware of the animals age and
of each other's classification of the tissue. A single rating
for each sample was then determined by consensus, al-
though commonly the determination was unanimous.
Based on nerve morphology, damage was rated using a
broad scale consisting of mild, moderate, and severe cat-
egories. Nerves estimated to contain 0-25 dark staining
axons per section and limited or no gliosis were rated as
mild. Normal nerves with no damage were included in
this category. Nerves estimated to contain greater than
25 dark staining axons per section but still maintaining a
significant portion of live axons were rated as moderate.
Nerves rated as severe contained numerous damaged ax-
ons throughout the nerve, had grossly disrupted nerve
morphology and sometimes contained few, if any,
healthy axons. Gliosis was present in some moderately
and severely damaged nerves.
Intraocular pressure measurement
IOPs were measured using a microneedle system as pre-
viously described [11, 54]. The IOPs of B6 mice are con-
sistent over time and so these animals were interspersed
with experimental mice to ensure that calibration had
not drifted and that the system was functioning optimal-
ly. The number of AKXD28 females (F) and males (M)
successfully analyzed at each age were: F7-10, n=19; M7-
10, n=8; F11-14, n=31; M11-14, n=21; F15-18, n=15; M15-
18, n=12; F19-21, n=12; M19-21, n=10. All measurements
were taken during the light-on phase of the recording
room. IOP values are given as mean ±  standard error of
the mean. Reported P values are from multifactorial
analysis of variance.BMC Genetics (2001) 2:1 http://www.biomedcentral.com/1471-2156/2/1
Measurement of glutamate levels
Aged mice were euthanized and eyes removed. Vitreous
was collected by inserting a pulled glass microcapillary
needle inserted approximately midway between the lim-
bus and optic nerve, and gently pressed posteriorly into
the vitreous at an angle avoiding the lens and retina. This
technique cleanly collected the more liquified vitreous.
Pilot experiments demonstrated that it is extremely dif-
ficult to harvest the more gelatinous vitreous that is intri-
cately associated with the retina without retinal
contamination. Vitreous was collected under a dissecting
microscope and any samples containing blood or other
visible debris were discarded. Collected vitreous was im-
mediately transferred to dry ice and stored at -80° C until
processed. Depending on the amount of vitreous collect-
ed per eye, samples from 2-4 eyes were pooled to obtain
a total volume of 10-15 µ l of vitreous. Sample pools for fe-
male (F) and male (M) mice were collected from mice 14
and 16 months old; the number of eyes contributing to
each sample pool was: F14, n=3; M14, n=3; F16, n=2;
M16, n=4. Each sample pool was diluted to a final vol-
ume of 70 µ l with cold Beckman Li-S buffer (96.8% H2O,
1% lithium citrate, 1% thiodiglycol, 0.7% hydrogen chlo-
ride, 0.5% benzoic acid, pH 2.2), transferred to an Ami-
con 30 microconcentrator (Amicon Inc., Beverly, MA),
and centrifuged at 16060 ×  g for 60 minutes at 4° C. The
concentrator was rinsed with 25 µ l of Li-S buffer and
centrifuged for 30 minutes. The combined filtrates were
brought to a total volume of 90 µ l with the same buffer.
The filtrates were divided into two and analyzed in dupli-
cate on a Beckman 6300 Amino Acid Analyzer fitted with
a 10 cm lithium column and the Beckman System Gold
data collection and analysis system (Beckman Instru-
ments Inc., Palo Alto, CA). Values for each filtrate were
determined from the mean of the duplicate analyses and
adjusted for the original volume of vitreous in each pool.
The separation of glutamate and glutamine was achieved
using Beckman's Li-A buffer (98% H2O, 1% lithium cit-
rate, 0.5% lithium chloride, 0.5% hydrogen chloride, pH
3.0). Standard curves validating the method and ensur-
ing accuracy over the experimental range of concentra-
tions measured were generated using 5 samples
containing known quantities of glutamate (50-1000
pmoles) and glutamine (100-3200 pmoles). Values for
glutamate levels at each age are reported as mean of the
female and male sample pools ±  the standard error of the
mean.
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